Back
GlycoMimetics Vs. Syros Pharmaceuticals Industry Stock Comparison
Sell
13
GLYC
GlycoMimetics
Last Price:
0.26
Seasonality Move:
17.05%
Buy
72
SYRS
Syros Pharmaceuticals
Last Price:
4.97
Seasonality Move:
11.1%
Sell
13
GlycoMimetics (GLYC)
is a Sell
Is GlycoMimetics a Buy, Sell or Hold?
- The current GlycoMimetics [GLYC] share price is $0.27. The Score for GLYC is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- GLYC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
72
Syros Pharmaceuticals (SYRS)
is a Buy
Is Syros Pharmaceuticals a Buy, Sell or Hold?
- The current Syros Pharmaceuticals [SYRS] share price is $4.97. The Score for SYRS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- SYRS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GLYC Stock Price Chart
What is GlycoMimetics's stock price today?
-
The GlycoMimetics share price today is $0.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLYC is experiencing slight buying pressure.
SYRS Stock Price Chart
What is Syros Pharmaceuticals's stock price today?
-
The Syros Pharmaceuticals share price today is $4.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRS is experiencing slight selling pressure.
GLYC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.57 | Sell |
| Relative Strength Index (14 RSI): | 20.19 | Sell |
| Chaikin Money Flow: | -1004233 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.93 - 2.45) | Sell |
| Bollinger Bands (100): | (1.89 - 3.29) | Sell |
SYRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 42.85 | Sell |
| Chaikin Money Flow: | -41841 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.86 - 5.48) | Sell |
| Bollinger Bands (100): | (5.36 - 7.3) | Sell |
GLYC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.83 | Sell |
| 20-day SMA: | 1.48 | Sell |
| 50-day SMA: | 2.26 | Sell |
| 200-day SMA: | 2.04 | Sell |
| 8-day EMA: | 0.71 | Sell |
| 20-day EMA: | 1.34 | Sell |
| 50-day EMA: | 1.98 | Sell |
| 200-day EMA: | 2.13 | Sell |
SYRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.12 | Sell |
| 20-day SMA: | 5.12 | Sell |
| 50-day SMA: | 5.67 | Sell |
| 200-day SMA: | 4.85 | Buy |
| 8-day EMA: | 5.08 | Sell |
| 20-day EMA: | 5.18 | Sell |
| 50-day EMA: | 5.53 | Sell |
| 200-day EMA: | 5.34 | Sell |
GlycoMimetics Earnings Growth & GLYC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Syros Pharmaceuticals Earnings Growth & SYRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and a decrease next year of $0.49 per share.
GlycoMimetics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Syros Pharmaceuticals Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||